Financhill
Back

Staar Surgical Quote, Financials, Valuation and Earnings

Buy
71

STAA
Staar Surgical

Last Price:
63.30
Seasonality Move:
2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Staar Surgical Price Quote

$63.30
-0.02 (7.05%)
(Updated: December 3, 2022 at 4:34 AM ET)

Staar Surgical Key Stats

Buy
71
Staar Surgical (STAA) is a Buy

Day range:
$57.61 - $63.69
52-week range:
$49.03 - $112.27
Dividend yield:
0%
P/E ratio:
126.64
P/S ratio:
11.19
P/B ratio:
9.5%

Volume:
973.9K
Avg. volume:
620K
1-year change:
-31.24%
Market cap:
$3B
Revenue:
$230.5M
EPS:
$0.76

How Much Does Staar Surgical Make?

Is Staar Surgical Growing As A Company?

  • What Is Staar Surgical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.3%
  • What Is Staar Surgical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.75%

Staar Surgical Stock Price Performance

  • Did Staar Surgical Stock Go Up Last Month?
    Staar Surgical share price went down by -10.34% last month
  • Did STAA's Share Price Rise Over The Last Year?
    STAA share price fell by -31.24% over the past 1 year

What Is Staar Surgical 52-Week High & Low?

Staar Surgical Price To Free Cash Flow

Is It Risky To Buy Staar Surgical?

  • How Much Debt Does Staar Surgical Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Staar Surgical Have?
    Cash and short term investments quarterly total is $211.3M
  • What Is Staar Surgical’s Book Value Per Share?
    Book value per share is 6.66

Is Staar Surgical Cash Flow Positive?

  • What Is STAA Cash Flow From Operations?
    Cash flow from operations (TTM) is $41.2M
  • What Is Staar Surgical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.9M
  • What Is Staar Surgical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$114.3M

Staar Surgical Return On Invested Capital

  • Is Management Doing A Good Job?
    STAA return on invested capital is 13.46%
  • What Is Staar Surgical Return On Assets?
    ROA measures how assets are converting to revenues and is 10.55%
  • What Is STAA Return On Equity?
    ROE is a measure of profitability and is 13.48%

Staar Surgical Earnings Date & Stock Price

Staar Surgical Competitors

  • Who Are Staar Surgical's Competitors?
    Below is a list of companies who compete with Staar Surgical or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • DexCom Inc (DXCM)
    • Neurocrine Biosciences Inc (NBIX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Staar Surgical Dividend Yield

Data Unavailable

Staar Surgical Analyst Estimates

YoY Growth Past Surprise
EPS: 75% 77.4%
Revenue: 30.32% 1.46%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 85.50
Upside from Last Price: 35.03%

Major Shareholders

  • How many STAA shares are owned by institutional investors?
    71.9M STAA shares are owned by institutional investors
  • How many STAA shares are owned by insiders?
    2.6M STAA shares are owned by insiders